These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18809892)

  • 1. Europeans claim industry handouts are not a problem.
    Eaton L
    CMAJ; 2008 Sep; 179(7):642-3. PubMed ID: 18809892
    [No Abstract]   [Full Text] [Related]  

  • 2. Spanish doctors say "no thank you" to drug industry gifts.
    Jara M
    BMJ; 2008 Sep; 337():a1579. PubMed ID: 18779223
    [No Abstract]   [Full Text] [Related]  

  • 3. No gifts, please, we're doctors.
    Kamerow D
    BMJ; 2009 May; 338():b1835. PubMed ID: 19423621
    [No Abstract]   [Full Text] [Related]  

  • 4. Should patient groups accept money from drug companies? Yes.
    Kent A
    BMJ; 2007 May; 334(7600):934. PubMed ID: 17478845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patient groups accept money from drug companies? No.
    Mintzes B
    BMJ; 2007 May; 334(7600):935. PubMed ID: 17478846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The illusion of invulnerability.
    Mansfield PR
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510114
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancerbackup sets record straight.
    Rule J
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510115
    [No Abstract]   [Full Text] [Related]  

  • 8. World Medical Association reviews doctors' links with drug companies.
    Mayor S
    BMJ; 2003 May; 326(7400):1165. PubMed ID: 12775604
    [No Abstract]   [Full Text] [Related]  

  • 9. Prohibiting gifts from industry representatives: a case study.
    Amdur RJ
    Am J Clin Oncol; 2009 Feb; 32(1):94-8. PubMed ID: 19194134
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated estimates of pharmaceutical company payments to physicians in Vermont.
    Ross JS; Nazem AG; Lurie P; Lackner JE; Krumholz HM
    JAMA; 2008 Nov; 300(17):1998-2000. PubMed ID: 18984886
    [No Abstract]   [Full Text] [Related]  

  • 11. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicians are not immune to marketing.
    Restuccia R; Rothman DJ; Chimonas S; Hams M
    J Am Coll Cardiol; 2007 Oct; 50(16):1615; author reply 1615-6. PubMed ID: 17936168
    [No Abstract]   [Full Text] [Related]  

  • 13. Are we providers or physicians?
    Baxter JD
    Arch Intern Med; 2009 Oct; 169(18):1725. PubMed ID: 19822834
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug industry loses bid to block disclosure of doctors' gifts.
    Burton B
    BMJ; 2007 Jul; 335(7609):12-3. PubMed ID: 17615200
    [No Abstract]   [Full Text] [Related]  

  • 15. Reframing relations with Pharma. Entanglement in Scotland.
    Ball DR; Kamel Y; Perkins V
    BMJ; 2009 Feb; 338():b763. PubMed ID: 19240096
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug company targets US state health officials.
    Moynihan R
    BMJ; 2004 Feb; 328(7435):306. PubMed ID: 14764476
    [No Abstract]   [Full Text] [Related]  

  • 17. Reframing relations with Pharma. Build rather than burn bridges.
    Damle A
    BMJ; 2009 Feb; 338():b765. PubMed ID: 19240098
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical sales reps: value beyond samples.
    Flewell MN
    Adv Nurse Pract; 2006 Jul; 14(7):18. PubMed ID: 16977890
    [No Abstract]   [Full Text] [Related]  

  • 19. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost and quality of industry-sponsored meals for medical residents.
    Grande D; Volpp K
    JAMA; 2003 Sep; 290(9):1150-1. PubMed ID: 12952992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.